PITPNA and hepatocellular carcinoma: To explore whether PITPNA-AS1 promotes HCC progression by modulating the miR-363-5p/PDGFD axis, we applied miR-363-5p inhibitor or overexpressed PDGFD in sh-PITPNA-AS1#1-transfected HCC cells.